Login Get Started
Browse
Shares
Healthcare
Pharmaceuticals
Cellectar Biosciences Inc
Cellectar Biosciences Inc logo

CLRB - Cellectar Biosciences Inc Share News

$1.21 0.0  2.5%

Last Trade - 7:04pm

Sector
Healthcare
RiskRating
Adventurous
Size
Micro Cap
Style
Sucker Stock
Market Cap £23.8m
Enterprise Value £7.06m
Revenue £n/a
Position in Universe 5131st / 6438
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions CLRB Dividends
All News
All News Reuters News Company Announcements
BRIEF-Cellectar Reports Q3 Loss Per Share Of $0.15
9th Nov News
Cellectar Reports Third Quarter 2020 Financial Results and Provides a Corporate Update
9th Nov News
BRIEF-Cellectar's Clr 131 Demonstrates Preliminary Activity In Inoperable Brain Tumors In Phase 1 Study
5th Nov News
Cellectar Biosciences’ CLR 131 Demonstrates Preliminary Activity in Phase I Study for Pediatric Brain and Solid Tumors
5th Nov News
Cellectar Biosciences to Present at Two Upcoming Investor Conferences
10th Sep News
BUZZ-Cellectar Biosciences jumps after promising data on cancer drug
9th Sep News
BRIEF-Cellectar Reports Data On Clr 131 Phase 2 Clover-1 Study In Triple Class Refractory Multiple Myeloma Patients
9th Sep News
Cellectar Reports Data on CLR 131 Phase 2 CLOVER-1 Study in Triple Class Refractory Multiple Myeloma Patients
9th Sep News
Cellectar Presents Poster at the AACR VIRTUAL MEETING: ADVANCES IN MALIGNANT LYMPHOMA
17th Aug News
BRIEF-Cellectar Biosciences Inc Files For Mixed Shelf Of Up To $100 Mln
11th Aug News
BRIEF-Cellectar Biosciences Says On Aug 11, Entered Into Equity Distribution Agreement With Oppenheimer & Co Inc
11th Aug News
BRIEF-Cellectar Q2 Loss Per Share $0.26
10th Aug News
Cellectar Reports Second Quarter 2020 Financial Results and Provides a Corporate Update
10th Aug News
BRIEF-Cellectar Announces Poster Presentation At The International Symposium On Pediatric Neuro-Oncology Annual Meeting
4th Aug News
Cellectar Announces Poster Presentation at the International Symposium on Pediatric Neuro-Oncology (ISPNO) Annual Meeting
4th Aug News
Cellectar Announces Poster Presentation of Clinical Data at the American Association of Cancer Research (AACR) Annual Meeting
21st Jul News
BRIEF-Lincoln Park Capital Fund Reports 8.92% Passive Stake In Cellectar Biosciences, Inc As Of July 11
13th Jul News
Cellectar Appoints Dr. John Friend as Chief Medical Officer
1st Jul News
BRIEF-Cellectar To Be Granted EU Patent For Phospholipid Ether Analogs As Cancer-Targeting Drug Vehicles
11th Jun News
Cellectar to be Granted EU Patent for Phospholipid Ether (PLE) Analogs as Cancer-Targeting Drug Vehicles
11th Jun News
© Stockopedia 2020, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.